Compare $INTI vs $VICP | Chartloom

Compare

$INTI vs $VICP

Inhibitor Therapeutics Inc · Vicapsys Life Sciences Inc

INTI

Inhibitor Therapeutics Inc

VICP

Vicapsys Life Sciences Inc

Compare $INTI vs $VICP

Comparing Inhibitor Therapeutics Inc and Vicapsys Life Sciences Inc

INTIInhibitor Therapeutics Inc

VICPVicapsys Life Sciences Inc

INTIInhibitor Therapeutics Inc

Market cap

$17M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

108.5%

52W performance

127.9%

FCF yield

-19.1%

VICPVicapsys Life Sciences Inc

Market cap

$18M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

-63.3%

52W performance

-68.9%

FCF yield

0.0%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

INTI

VICP

Detailed metrics comparison

INTI

Inhibitor Therapeutics Inc

VICP

Vicapsys Life Sciences Inc

Market Cap

INTI$17M

VICP$18M

Enterprise Value

INTI$16M

VICP$18M

Price

INTI$0.10

VICP$0.55

P/E Ratio

INTIN/A

VICPN/A

P/S Ratio

INTI4.25x

VICP0.00x

EV/Sales

INTI4.12x

VICP0.00x

EV/EBITDA

INTI1.61x

VICP0.00x

P/B Ratio

INTI4,922.43x

VICPN/A

P/FCF Ratio

INTIN/A

VICPN/A

EV/FCF

INTI-5.09x

VICP0.00x

PEG Ratio

INTIN/A

VICPN/A

Forward P/E (NTM)

INTIN/A

VICPN/A

Forward P/S (NTM)

INTIN/A

VICPN/A

Revenue (TTM)

INTI$0

VICP$0

Revenue Growth (YoY)

INTIN/A

VICPN/A

Forward Rev Growth

INTI0.0%

VICP0.0%

Gross Margin (TTM)

INTI20.9%

VICP0.0%

Operating Margin (TTM)

INTI0.0%

VICP0.0%

EBITDA Margin (TTM)

INTI0.0%

VICP0.0%

Net Margin (TTM)

INTI0.0%

VICP0.0%

FCF Margin (TTM)

INTIN/A

VICPN/A

Net Income (TTM)

INTI$-3M

VICPN/A

FCF (TTM)

INTI$-3M

VICP$0

EPS (TTM)

INTI$0.00

VICP$0.00

ROE (TTM)

INTI-33792.0%

VICP0.0%

ROA (TTM)

INTI-12210.0%

VICP0.0%

ROIC (TTM)

INTI-33792.0%

VICP0.0%

Cash

INTI$516K

VICP$90K

Debt

INTI$0

VICP$579K

Net Cash/Debt

INTI$516K

VICP$-489K

Current Ratio (TTM)

INTI3.36x

VICP0.03x

Quick Ratio (TTM)

INTI2.95x

VICP0.03x

Debt/Equity (TTM)

INTI0.00x

VICP0.00x

Debt/Assets (TTM)

INTI0.0%

VICP0.0%

Interest Coverage (TTM)

INTIN/A

VICPN/A

Net Debt/EBITDA (TTM)

INTI0.00x

VICP0.00x

Beta

INTI-0.79

VICP-3.98

52W Performance

INTI127.9%

VICP-68.9%

YTD Performance

INTI108.5%

VICP-63.3%

% from 52W High

INTI-21.0%

VICP-68.9%

% from 52W Low

INTI180.0%

VICP399.9%

Asset Turnover (TTM)

INTI0.50x

VICP0.00x

FCF Yield (TTM)

INTI-19.1%

VICP0.0%

Earnings Yield (TTM)

INTI-15.9%

VICP0.0%

Dividend Yield (TTM)

INTIN/A

VICPN/A

Rule of 40

INTI0.0

VICP0.0

EV/GP/RG

INTIN/A

VICPN/A

Ticker research

View INTI research View VICP research

Metric	INTI Inhibitor Therapeutics Inc	VICP Vicapsys Life Sciences Inc
Market & Valuation
Market Cap	$17M	$18M
Enterprise Value	$16M	$18M
Price	$0.10	$0.55
P/E Ratio	N/A	N/A
P/S Ratio	4.25x	0.00x
EV/Sales	4.12x	0.00x
EV/EBITDA	1.61x	0.00x
P/B Ratio	4,922.43x	N/A
P/FCF Ratio	N/A	N/A
EV/FCF	-5.09x	0.00x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$0	$0
Revenue Growth (YoY)	N/A	N/A
Forward Rev Growth	0.0%	0.0%
Profitability
Gross Margin (TTM)	20.9%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	0.0%
Net Margin (TTM)	0.0%	0.0%
FCF Margin (TTM)	N/A	N/A
Net Income (TTM)	$-3M	N/A
FCF (TTM)	$-3M	$0
EPS (TTM)	$0.00	$0.00
ROE (TTM)	-33792.0%	0.0%
ROA (TTM)	-12210.0%	0.0%
ROIC (TTM)	-33792.0%	0.0%
Financial Health
Cash	$516K	$90K
Debt	$0	$579K
Net Cash/Debt	$516K	$-489K
Current Ratio (TTM)	3.36x	0.03x
Quick Ratio (TTM)	2.95x	0.03x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	-0.79	-3.98
52W Performance	127.9%	-68.9%
YTD Performance	108.5%	-63.3%
% from 52W High	-21.0%	-68.9%
% from 52W Low	180.0%	399.9%
Efficiency & Yields
Asset Turnover (TTM)	0.50x	0.00x
FCF Yield (TTM)	-19.1%	0.0%
Earnings Yield (TTM)	-15.9%	0.0%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	0.0
EV/GP/RG	N/A	N/A
Ticker research	View INTI research	View VICP research

Valuation

P/S Ratio

VICP

0.00x

INTI

4.25x

EV/FCF

INTI

-5.09x

VICP

0.00x

Growth & revenue

Forward Revenue Growth

INTI

0.0%

VICP

0.0%

Profitability & performance

Gross Margin

INTI

20.9%

VICP

0.0%

ROE

VICP

0.0%

INTI

-33792.0%

FCF Yield %

VICP

0.0%

INTI

-19.1%

52-Week Performance

INTI

127.9%

VICP

-68.9%

Detailed metrics comparison

INTI

Inhibitor Therapeutics Inc

VICP

Vicapsys Life Sciences Inc

Market Cap

INTI$17M

VICP$18M

Enterprise Value

INTI$16M

VICP$18M

Price

INTI$0.10

VICP$0.55

P/E Ratio

INTIN/A

VICPN/A

P/S Ratio

INTI4.25x

VICP0.00x

EV/Sales

INTI4.12x

VICP0.00x

EV/EBITDA

INTI1.61x

VICP0.00x

P/B Ratio

INTI4,922.43x

VICPN/A

P/FCF Ratio

INTIN/A

VICPN/A

EV/FCF

INTI-5.09x

VICP0.00x

PEG Ratio

INTIN/A

VICPN/A

Forward P/E (NTM)

INTIN/A

VICPN/A

Forward P/S (NTM)

INTIN/A

VICPN/A

Revenue (TTM)

INTI$0

VICP$0

Revenue Growth (YoY)

INTIN/A

VICPN/A

Forward Rev Growth

INTI0.0%

VICP0.0%

Gross Margin (TTM)

INTI20.9%

VICP0.0%

Operating Margin (TTM)

INTI0.0%

VICP0.0%

EBITDA Margin (TTM)

INTI0.0%

VICP0.0%

Net Margin (TTM)

INTI0.0%

VICP0.0%

FCF Margin (TTM)

INTIN/A

VICPN/A

Net Income (TTM)

INTI$-3M

VICPN/A

FCF (TTM)

INTI$-3M

VICP$0

EPS (TTM)

INTI$0.00

VICP$0.00

ROE (TTM)

INTI-33792.0%

VICP0.0%

ROA (TTM)

INTI-12210.0%

VICP0.0%

ROIC (TTM)

INTI-33792.0%

VICP0.0%

Cash

INTI$516K

VICP$90K

Debt

INTI$0

VICP$579K

Net Cash/Debt

INTI$516K

VICP$-489K

Current Ratio (TTM)

INTI3.36x

VICP0.03x

Quick Ratio (TTM)

INTI2.95x

VICP0.03x

Debt/Equity (TTM)

INTI0.00x

VICP0.00x

Debt/Assets (TTM)

INTI0.0%

VICP0.0%

Interest Coverage (TTM)

INTIN/A

VICPN/A

Net Debt/EBITDA (TTM)

INTI0.00x

VICP0.00x

Beta

INTI-0.79

VICP-3.98

52W Performance

INTI127.9%

VICP-68.9%

YTD Performance

INTI108.5%

VICP-63.3%

% from 52W High

INTI-21.0%

VICP-68.9%

% from 52W Low

INTI180.0%

VICP399.9%

Asset Turnover (TTM)

INTI0.50x

VICP0.00x

FCF Yield (TTM)

INTI-19.1%

VICP0.0%

Earnings Yield (TTM)

INTI-15.9%

VICP0.0%

Dividend Yield (TTM)

INTIN/A

VICPN/A

Rule of 40

INTI0.0

VICP0.0

EV/GP/RG

INTIN/A

VICPN/A

Ticker research

View INTI research View VICP research

Metric	INTI Inhibitor Therapeutics Inc	VICP Vicapsys Life Sciences Inc
Market & Valuation
Market Cap	$17M	$18M
Enterprise Value	$16M	$18M
Price	$0.10	$0.55
P/E Ratio	N/A	N/A
P/S Ratio	4.25x	0.00x
EV/Sales	4.12x	0.00x
EV/EBITDA	1.61x	0.00x
P/B Ratio	4,922.43x	N/A
P/FCF Ratio	N/A	N/A
EV/FCF	-5.09x	0.00x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$0	$0
Revenue Growth (YoY)	N/A	N/A
Forward Rev Growth	0.0%	0.0%
Profitability
Gross Margin (TTM)	20.9%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	0.0%
Net Margin (TTM)	0.0%	0.0%
FCF Margin (TTM)	N/A	N/A
Net Income (TTM)	$-3M	N/A
FCF (TTM)	$-3M	$0
EPS (TTM)	$0.00	$0.00
ROE (TTM)	-33792.0%	0.0%
ROA (TTM)	-12210.0%	0.0%
ROIC (TTM)	-33792.0%	0.0%
Financial Health
Cash	$516K	$90K
Debt	$0	$579K
Net Cash/Debt	$516K	$-489K
Current Ratio (TTM)	3.36x	0.03x
Quick Ratio (TTM)	2.95x	0.03x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	-0.79	-3.98
52W Performance	127.9%	-68.9%
YTD Performance	108.5%	-63.3%
% from 52W High	-21.0%	-68.9%
% from 52W Low	180.0%	399.9%
Efficiency & Yields
Asset Turnover (TTM)	0.50x	0.00x
FCF Yield (TTM)	-19.1%	0.0%
Earnings Yield (TTM)	-15.9%	0.0%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	0.0
EV/GP/RG	N/A	N/A
Ticker research	View INTI research	View VICP research